Skip to main content
Erschienen in: Medical Oncology 4/2010

01.12.2010 | Original Paper

Upregulation of soluble resistance-related calcium-binding protein (sorcin) in gastric cancer

verfasst von: Langmei Deng, Tao Su, Aimin Leng, Xiaomei Zhang, Meihua xu, Lu Yan, Huan Gu, Guiying Zhang

Erschienen in: Medical Oncology | Ausgabe 4/2010

Einloggen, um Zugang zu erhalten

Abstract

The aim of this paper was to identify novel proteins involved in the development of gastric cancer (GC). Isobaric tags for relative and absolute quantification (iTRAQ) analysis was adopted to separate the differentially expressed proteins between normal gastric epithelial cell line GES-1 and GC cell line SGC7901. Western blotting was utilized to validate the increased expression of sorcin in SGC7901; immunohistochemistry was performed to investigate its relationship with clinicopathological features of GC. Twelve differential proteins were identified. Seven proteins were found to be significantly upregulated (≥twofold), while five proteins were markedly downregulated (≤0.5-fold), in SGC7901 cells. Sorcin was detected by this proteomic approach with a 5.4-fold upregulation in SGC7901. Western blotting and immunohistochemistry confirmed the overexpression of sorcin in GC. Immunohistochemistry showed us that sorcin was overexpressed in 55 samples of GC tissue (55/85, 64.71%) and was related closely to the depth of invasion, TNM stage, and lymph node metastasis of GC (P < 0.05). The development of GC is regulated by multiple genes. Sorcin will be a novel molecular biomarker for the diagnosis, treatment, and prognosis of GC.
Literatur
1.
Zurück zum Zitat Ohgaki H, Matsukura N. Stomach cancer. In: Stewart BW, Kleihues P, editors. World cancer report. Lyon: IARC Press; 2003. p. 197–207. Ohgaki H, Matsukura N. Stomach cancer. In: Stewart BW, Kleihues P, editors. World cancer report. Lyon: IARC Press; 2003. p. 197–207.
2.
Zurück zum Zitat Roth AD. Curative treatment of gastric cancer: towards a multidisciplinary approach? Crit Rev Oncol Hematol. 2003;46:59–100.PubMedCrossRef Roth AD. Curative treatment of gastric cancer: towards a multidisciplinary approach? Crit Rev Oncol Hematol. 2003;46:59–100.PubMedCrossRef
3.
Zurück zum Zitat Ellis DJ, Speirs C, Kingston RD, Brookes VS, Leonard J, Dykes PW. Carcinoembryonic antigen levels in advanced gastric carcinoma. Cancer (Phila.). 1978;42:623–5.CrossRef Ellis DJ, Speirs C, Kingston RD, Brookes VS, Leonard J, Dykes PW. Carcinoembryonic antigen levels in advanced gastric carcinoma. Cancer (Phila.). 1978;42:623–5.CrossRef
4.
Zurück zum Zitat Sikoroska H, Shuster J, Gold P. Clinical application of carcinoembryonic antigen. Cancer Detect Prev. 1988;12:321–55. Sikoroska H, Shuster J, Gold P. Clinical application of carcinoembryonic antigen. Cancer Detect Prev. 1988;12:321–55.
5.
Zurück zum Zitat Ritts R, Del Villano B, Go VL, Herberman RB, Klug TL, Zurawski VR Jr. Initial clinical evaluation of an immunoradiometric assay for CA19-9 using the NCI serum bank. Int J Cancer. 1984;33:339–45.PubMedCrossRef Ritts R, Del Villano B, Go VL, Herberman RB, Klug TL, Zurawski VR Jr. Initial clinical evaluation of an immunoradiometric assay for CA19-9 using the NCI serum bank. Int J Cancer. 1984;33:339–45.PubMedCrossRef
7.
Zurück zum Zitat Zhang J, Sui J, Ching CB, Chen WN. Protein profile in neuroblastoma cells incubated with S- and R-enantiomers of ibuprofen by iTRAQ-coupled 2-D LC–MS/MS analysis: possible action of induced proteins on Alzheimer’s disease. Proteomics. 2008;8:1595–607.PubMedCrossRef Zhang J, Sui J, Ching CB, Chen WN. Protein profile in neuroblastoma cells incubated with S- and R-enantiomers of ibuprofen by iTRAQ-coupled 2-D LC–MS/MS analysis: possible action of induced proteins on Alzheimer’s disease. Proteomics. 2008;8:1595–607.PubMedCrossRef
8.
Zurück zum Zitat Lu H, Yang Y, Allister EM, Wijesekara N, Wheeler MB. The identification of potential factors associated with the development of type 2 diabetes: a quantitative proteomics approach. Mol Cell Proteomics. 2008;7:1434–51.PubMedCrossRef Lu H, Yang Y, Allister EM, Wijesekara N, Wheeler MB. The identification of potential factors associated with the development of type 2 diabetes: a quantitative proteomics approach. Mol Cell Proteomics. 2008;7:1434–51.PubMedCrossRef
9.
Zurück zum Zitat Yokota T, et al. Identification of histological markers for malignant glioma by genome-wide expression analysis dynein a-PIX and sorcin. Acta Neuropathol. 2006;111:29–38.PubMedCrossRef Yokota T, et al. Identification of histological markers for malignant glioma by genome-wide expression analysis dynein a-PIX and sorcin. Acta Neuropathol. 2006;111:29–38.PubMedCrossRef
10.
Zurück zum Zitat Glen A, et al. iTRAQ-facilitated proteomic analysis of human prostate cancer cells identifies proteins associated with progression. J Proteome Res. 2008;7(3):897–907.PubMedCrossRef Glen A, et al. iTRAQ-facilitated proteomic analysis of human prostate cancer cells identifies proteins associated with progression. J Proteome Res. 2008;7(3):897–907.PubMedCrossRef
11.
Zurück zum Zitat Keshamouni VG, et al. Differential protein expression profiling by iTRAQ- 2DLC-MS/MS of lung cancer cells undergoing epithelial-mesenchymal transition reveals a migratory/invasive phenotype. J Proteome Res. 2006;5:1143–54.PubMedCrossRef Keshamouni VG, et al. Differential protein expression profiling by iTRAQ- 2DLC-MS/MS of lung cancer cells undergoing epithelial-mesenchymal transition reveals a migratory/invasive phenotype. J Proteome Res. 2006;5:1143–54.PubMedCrossRef
12.
Zurück zum Zitat Armah HB, Parwani AV. Epithelioid sarcoma. Arch Pathol Lab Med. 2009;133(5):814–9.PubMed Armah HB, Parwani AV. Epithelioid sarcoma. Arch Pathol Lab Med. 2009;133(5):814–9.PubMed
13.
Zurück zum Zitat Zheng LD, et al. Gastric carcinoma with osteoclast-like giant cells: a case report and review of the literature. J Zhejiang Univ Sci B. 2009;10(3):237–41.PubMedCrossRef Zheng LD, et al. Gastric carcinoma with osteoclast-like giant cells: a case report and review of the literature. J Zhejiang Univ Sci B. 2009;10(3):237–41.PubMedCrossRef
14.
Zurück zum Zitat Izdebska M, Grzanka A, Ostrowski M. The cytoskeleton reorganization and differentiation of HL-60 and K-562 human leukemia cell lines. Postepy Hig Med Dosw (Online). 2006;60:64–70. Izdebska M, Grzanka A, Ostrowski M. The cytoskeleton reorganization and differentiation of HL-60 and K-562 human leukemia cell lines. Postepy Hig Med Dosw (Online). 2006;60:64–70.
15.
Zurück zum Zitat Zhang X, Xu W. Aminopeptidase N (APN/CD13) as a target for anti-cancer agent design. Curr Med Chem. 2008;15(27):2850–65.PubMedCrossRef Zhang X, Xu W. Aminopeptidase N (APN/CD13) as a target for anti-cancer agent design. Curr Med Chem. 2008;15(27):2850–65.PubMedCrossRef
16.
Zurück zum Zitat Badea L, Herlea V, Dima SO, Dumitrascu T, Popescu I. Combined gene expression analysis of whole-tissue and microdissected pancreatic ductal adenocarcinoma identifies genes specifically overexpressed in tumor epithelia. Hepatogastroenterology. 2008;55(88):2016–27.PubMed Badea L, Herlea V, Dima SO, Dumitrascu T, Popescu I. Combined gene expression analysis of whole-tissue and microdissected pancreatic ductal adenocarcinoma identifies genes specifically overexpressed in tumor epithelia. Hepatogastroenterology. 2008;55(88):2016–27.PubMed
17.
18.
Zurück zum Zitat Perut F, et al. Immunogenic properties of renal cell carcinoma and the pathogenesis of osteolytic bone metastases. Int J Oncol. 2009;34(5):1387–93.PubMed Perut F, et al. Immunogenic properties of renal cell carcinoma and the pathogenesis of osteolytic bone metastases. Int J Oncol. 2009;34(5):1387–93.PubMed
19.
Zurück zum Zitat Kondo T, et al. ERM (ezrin/radixin/moesin)-based molecular mechanism of microvillar breakdown at an early stage of apoptosis. J Cell Biol. 1997;139(3):749–58.PubMedCrossRef Kondo T, et al. ERM (ezrin/radixin/moesin)-based molecular mechanism of microvillar breakdown at an early stage of apoptosis. J Cell Biol. 1997;139(3):749–58.PubMedCrossRef
20.
Zurück zum Zitat Kannan K, et al. Lysosome-associated membrane proteins h-LAMP1 (CD107a) and h-LAMP2 (CD107b) are activation-dependent cell surface glycoproteins in human peripheral blood mononuclear cells which mediate cell adhesion to vascular endothelium. Cell Immunol. 1996;171(1):10–9.PubMedCrossRef Kannan K, et al. Lysosome-associated membrane proteins h-LAMP1 (CD107a) and h-LAMP2 (CD107b) are activation-dependent cell surface glycoproteins in human peripheral blood mononuclear cells which mediate cell adhesion to vascular endothelium. Cell Immunol. 1996;171(1):10–9.PubMedCrossRef
21.
Zurück zum Zitat Mizuuchi E, Semba S, Kodama Y, Yokozaki H. Down-modulation of keratin 8 phosphorylation levels by PRL-3 contributes to colorectal carcinoma progression. Int J Cancer. 2009;124(8):1802–10.PubMedCrossRef Mizuuchi E, Semba S, Kodama Y, Yokozaki H. Down-modulation of keratin 8 phosphorylation levels by PRL-3 contributes to colorectal carcinoma progression. Int J Cancer. 2009;124(8):1802–10.PubMedCrossRef
22.
Zurück zum Zitat Kim TM, et al. Determination of genes related to gastrointestinal tract origin cancer cells using a cDNA microarray. Clin Cancer Res. 2005;11(1):79–86.PubMed Kim TM, et al. Determination of genes related to gastrointestinal tract origin cancer cells using a cDNA microarray. Clin Cancer Res. 2005;11(1):79–86.PubMed
23.
Zurück zum Zitat Kralovánszky J, Szentirmay Z, Besznyák I, Eckhardt S. Placental type alkaline phosphatase in possibly premalignant alterations of human gastric mucosa. Oncology. 1984;41(3):189–94.PubMedCrossRef Kralovánszky J, Szentirmay Z, Besznyák I, Eckhardt S. Placental type alkaline phosphatase in possibly premalignant alterations of human gastric mucosa. Oncology. 1984;41(3):189–94.PubMedCrossRef
24.
Zurück zum Zitat Marian MB, et al. Association of sorcin with the cardiac ryanodine receptor. J Biol Chem. 1995;270(44):26411–8.CrossRef Marian MB, et al. Association of sorcin with the cardiac ryanodine receptor. J Biol Chem. 1995;270(44):26411–8.CrossRef
25.
Zurück zum Zitat Nagpal JK, Das BR. Identification of differentially expressed genes in tobacco chewing-mediated oral cancer by differential display-polymerase chain reaction. Eur J Clin Invest. 2007;37(8):658–64.PubMedCrossRef Nagpal JK, Das BR. Identification of differentially expressed genes in tobacco chewing-mediated oral cancer by differential display-polymerase chain reaction. Eur J Clin Invest. 2007;37(8):658–64.PubMedCrossRef
26.
Zurück zum Zitat Meyers MB, Biedler JL. Increased synthesis of a low molecular weight protein in vincristine-resistant cells. Biochem Biophys Res Commun. 1981;99:228–35.PubMedCrossRef Meyers MB, Biedler JL. Increased synthesis of a low molecular weight protein in vincristine-resistant cells. Biochem Biophys Res Commun. 1981;99:228–35.PubMedCrossRef
27.
Zurück zum Zitat Meyers MB. Sorcin: a calcium-binding protein overproduced in many multidrug-resistant cells. In: Smith VL, Dedman JR, editors. Stimulus response coupling: the role of intracellular calcium-binding proteins, Boca Raton: CRC Press Inc; 1990. p. 159–171. Meyers MB. Sorcin: a calcium-binding protein overproduced in many multidrug-resistant cells. In: Smith VL, Dedman JR, editors. Stimulus response coupling: the role of intracellular calcium-binding proteins, Boca Raton: CRC Press Inc; 1990. p. 159–171.
28.
Zurück zum Zitat Yang Y-X, Chen Z–C, Zhang G-Y, Yi H, Xiao Z-Q. A subcelluar proteomic investigation into vincristine-resistant gastric cancer cell line. J Cell Biochem. 2008;104:1010–21.PubMedCrossRef Yang Y-X, Chen Z–C, Zhang G-Y, Yi H, Xiao Z-Q. A subcelluar proteomic investigation into vincristine-resistant gastric cancer cell line. J Cell Biochem. 2008;104:1010–21.PubMedCrossRef
29.
Zurück zum Zitat He QC, Zhang GY, Cao WJ. Correlation of sorcin overexpression to multidrug resistance of human gastric cancer cell line SGC7901. Ai Zheng. 2008;27(4):337–42.PubMed He QC, Zhang GY, Cao WJ. Correlation of sorcin overexpression to multidrug resistance of human gastric cancer cell line SGC7901. Ai Zheng. 2008;27(4):337–42.PubMed
Metadaten
Titel
Upregulation of soluble resistance-related calcium-binding protein (sorcin) in gastric cancer
verfasst von
Langmei Deng
Tao Su
Aimin Leng
Xiaomei Zhang
Meihua xu
Lu Yan
Huan Gu
Guiying Zhang
Publikationsdatum
01.12.2010
Verlag
Springer US
Erschienen in
Medical Oncology / Ausgabe 4/2010
Print ISSN: 1357-0560
Elektronische ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-009-9342-5

Weitere Artikel der Ausgabe 4/2010

Medical Oncology 4/2010 Zur Ausgabe

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.